Cargando…
Patterns and trends of potentially inappropriate high-density lipoprotein cholesterol testing in Australian adults at high risk of cardiovascular disease from 2008 to 2014: analysis of linked individual patient data from the Australian Medicare Benefits Schedule and Pharmaceutical Benefits Scheme
OBJECTIVES: We examine the extent to which the adult Australian population on lipid-lowering medications receives the level of high-density lipoprotein cholesterol (HDL-C) testing recommended by national guidelines. DATA: We analysed records from 7 years (2008–2014) of the 10% publicly available sam...
Autores principales: | Hajati, Farshid, Atlantis, Evan, Bell, Katy J L, Girosi, Federico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5855213/ https://www.ncbi.nlm.nih.gov/pubmed/29523561 http://dx.doi.org/10.1136/bmjopen-2017-019041 |
Ejemplares similares
-
Predicting diabetes second-line therapy initiation in the Australian population via time span-guided neural attention network
por: Fiorini, Samuele, et al.
Publicado: (2019) -
The Australian Pharmaceutical Benefits Scheme data collection: a practical guide for researchers
por: Mellish, Leigh, et al.
Publicado: (2015) -
Australian Pharmaceutical Benefits scheme data on utilisation of intravitreal therapy in retinal vein occlusion
por: Mitchell, Paul, et al.
Publicado: (2022) -
Has the Child Dental Benefits Schedule improved access to dental care for Australian children?
por: Stormon, Nicole, et al.
Publicado: (2022) -
HIV treatment regimens and adherence to national guidelines in Australia: an analysis of dispensing data from the Australian pharmaceutical benefits scheme
por: Dharan, Nila J., et al.
Publicado: (2019)